“Please governments, keep on investing in basic science”, Paul Stoffels, Chief Science Officer of Johnson & Johnson, implored at the inaugural symposium of the Janssen Prevention Center (JPC) of Janssen Pharmaceutical Companies. The new research centre was established early 2015 and organised its first symposium titled “Reaching for immorbidity” on June 4th at the EYE Film Institute in Amsterdam. Continue reading
Showing articles tagged with 'Alzheimer's Disease'
The accumulation of amyloid in brain tissue is an early sign of Alzheimer’s disease. An elaborate study from the VUmc Alzheimer Centre and the University Medical Centre of Maastricht has now identified these plaques in ten percent of healthy fifty year-olds. Furthermore, the protein accumulations seem to occur more frequent in people with a higher education. These results were published in JAMA. Continue reading
A skin test might shed new light on Alzheimer’s and Parkinson’s diseases, according to a study that will be presented at the American Academy of Neurology’s 67th Annual Meeting in Washington, D.C., April 18 to 25, 2015. The study showed that skin biopsies can be used to detect elevated levels of abnormal proteins found in the two diseases. Continue reading
Also this week MedZine brings you the latest medical news on various medical specialisms. In this editorial two striking studies in the field of neurology are highlighted. The first identifies an inhibitor that slows neuronal degeneration and shows potential as a therapy against Alzheimer’s disease. The second describes how muscles accidentally fall asleep while someone is awake. Continue reading
On September 21st it is World Alzheimer’s Day, the climax of the World Alzheimer’s Month. Since 1994 World Alzheimer’s Day has been held on September 21st to raise awareness for the disease. Continue reading
Also this week MedZine brings you the latest medical news on various medical specialisms. In this editorial some striking studies are highlighted. This week we have selected two studies, both concerning neurological breakthroughs. The first describes the development of a process that renders a whole brain transparent. The second study sheds light on one of the major toxic mechanisms of Alzheimer's disease. Continue reading